Neurological disorders are one of the most feared diseases in the world and Axxam is taking part of the worldwide efforts to find new treatments. Meet with our representatives on the event platform or contact us directly to which assets we offer to our clients to support their discovery projects in the neuroscience field.

Just as a small anticipation, we are delighted to inform you that our compound collection includes a subset of small molecules selected for their optimized MPO scores and specifically biased for CNS, pain and intracellular targets.